$AIFF

FIREFLY NEUROSCIENCE, INC. (AIFF): Termination of a Material Definitive Agreement

FIREFLY NEUROSCIENCE, INC. (AIFF) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. false 0000803578 0000803578 2026-06-25 2026-06-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Repor

Original reporting
Published Jun 26, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 26, 2026, 8:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$AIFF
Bearish
medium confidence
Mentioned
$AIFF
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AIFFBearishMed
01

Why it matters

Mutual termination effective June 25, 2026 eliminates the contractual issuance pathway under the prior agreement, which can pressure liquidity expectations and increase the probability of alternative financing.

02

Market read

This is a direct, company-specific financing development disclosed via SEC 8-K, relevant for assessing near-term funding risk and potential dilution expectations.

03

What to watch

The filing does not state whether any units were already sold under the Purchase Agreement; traders should check the May 12, 2026 8-K and any subsequent amendments/closings to gauge how much capital was actually secured.

Relevance 6/10Novelty 6/10Timing: after-hours / filed June 26, 2026 following June 25 termination effective date

Background

The company previously disclosed a May 6, 2026 securities purchase agreement to issue/sell up to 666,667 units at $1.50 per unit for up to $1.0M gross proceeds.

Company-level read

Ticker impact

$AIFFBearishMedium confidence
Context

Firefly Neuroscience terminated its May 6, 2026 securities purchase agreement with an accredited investor, effective June 25, 2026.

Expected impact

Near-term downside bias as the market reassesses liquidity and funding runway; volatility likely elevated until a replacement financing is announced.

Evidence & confidence

The 8-K discloses a mutual written termination of a material definitive purchase agreement, directly affecting the company’s ability to raise the contemplated proceeds.

Market effects

Adds to the broader read-through that small-cap life-science issuers may face deal churn and funding execution risk.

Limited; primarily impacts Nasdaq-listed micro/small-cap sentiment.

Low; company-specific financing event with minimal cross-border spillover.

Counterpoint

The termination could reflect a planned renegotiation or a shift to a different financing structure rather than a true funding failure.

Key entities

  • FIREFLY NEUROSCIENCE, INC.

    Nasdaq-listed issuer that terminated a material securities purchase agreement effective June 25, 2026.

  • Investor (accredited investor)

    Accredited investor party to the terminated Purchase Agreement; no identity provided in the filing excerpt.

Related articles

$AIFFHighAI 8/10

AI Stock Firefly Neuroscience (NASDAQ: AIFF) Soars on First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly Neuroscience (NASDAQ: AIFF) stock surged 32.77% after announcing a partnership with NeuroSigma to expand access to the FDA-cleared Monarch eTNS(R) System, a non-drug treatment for pediatric ADHD. The stock traded at $1.58 on high volume. Firefly's Evoke(TM) platform provides AI-powered brain function analytics to clinicians. According to a 2024 study, approximately 7.1 million U.S. children have been diagnosed with ADHD, with nearly one-third receiving no treatment.

$AIFFHigh

Firefly Hikes on Partnering with NeuroSigma

Firefly Neuroscience (AIFF) and NeuroSigma partnered to promote NeuroSigma's Monarch eTNS System, a non-drug ADHD treatment, through Firefly's Evoke platform network. AIFF shares rose 38.9% to $1.65. According to a 2024 study, 7.1 million U.S. children have ADHD, with many seeking non-medication treatments.

$AIBMedAI 9/10

BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build

BlockchAIn Digital Infrastructure (AIB) announced an $800M data center build funded by Nebius prepayments. The project, expected to start cash flows in Q4 2027, will have 50 MW capacity. AIB aims for 90% EBITDA margins and prefers investments at the project level, with no conversion into common stock. The company has additional sites totaling 280 MW of potential capacity.